Nature-based Treatment Group for Depression
The Effects of Nature-based Intervention in the Treatment of Depression: Multi-center, Randomized Controlled Trial in Finland
1 other identifier
interventional
147
1 country
3
Brief Summary
This multi-centre research investigates the effects of nature-based treatment group on participants diagnosed with depression. In total, 147 persons participated in the study in various locations in Finland. All participants received treatment as usual (TAU). They were randomised into nature-based group + TAU (n = 70) or TAU-only (n = 77). The participants in the nature-based group + TAU were offered 12 sessions once a week in addition to standard care. The measurement points included pre-treatment measurement at the baseline and post-treatment measurement at the end of the intervention, which was 12 weeks after the pre-treatment measurement. The follow-up measurement was 3 months after the post-treatment measurement. The effects of the intervention were assessed with a clinical measure of depression (BDI-I) and with indicators of psychological distress (CORE-10), subjective well-being (SWEMWBS), work/study ability (WAI) and nature experiences (ROS, KOLU). The participants in the treatment group (nature-based group +TAU) were compared to the participants in the control group who received TAU-only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jan 2019
Typical duration for not_applicable depression
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedFirst Submitted
Initial submission to the registry
May 18, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedJuly 1, 2021
June 1, 2021
2.2 years
May 18, 2021
June 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline depressive symptoms (Beck Depression Inventory; BDI-I) at 12-week post-treatment measurement.
BDI-I (Beck Depression Inventory - I) measures depressive symptoms with 21 items. Each item is scored 0-3 and sum scores are calculated on the basis of participants' responses. The total sum score can range from 0 to 63 and higher score indicates higher depression.
12 weeks
Change from post-treatment depressive symptoms (Beck Depression Inventory-I; BDI-I) at three-month follow-up measurement.
The change in depressive symptoms between the post-treatment measurement at the end of the 12-week intervention and the 3-month follow-up. BDI-I (Beck Depression Inventory - I) measures depressive symptoms with 21 items. Each item is scored 0-3 and sum scores are calculated on the basis of participants' responses. The total sum score can range from 0 to 63 and higher score indicates higher depression.
3 months
Study Arms (2)
Nature-based treatment group
EXPERIMENTALThe participants in the treatment group were offered 12 nature-based group therapy sessions in addition to standard care.
Control group
NO INTERVENTIONThe participants in the control group continued treatment as usual in the health care services.
Interventions
Nature-based intervention was facilitated by a health care professional and included 12 x 90 mins sessions within 12 weeks.
Eligibility Criteria
You may qualify if:
- A diagnoses of depression (ICD -diagnostic system)
- BDI-I score 10 or above
- Treatment contact in a health care service
- Motivated to commit to a 12-session treatment group taking place in nearby nature environments
- Able to communicate adequately in Finnish in order to participate
You may not qualify if:
- Active suicidal ideation
- Psychotic symptoms
- Substance misuse that is on a critical level
- Volunteers who had pain-related problems that restricted daily life or were pregnant were not admitted to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- JAMK University Of Applied Scienceslead
- Tampere Universitycollaborator
- University of Jyvaskylacollaborator
Study Sites (3)
University of Jyväskylä
Jyväskylä, 40014, Finland
Institute of Rehabilitation, JAMK University of Applied Sciences
Jyväskylä, 40100, Finland
Tampere University
Tampere, 33100, Finland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kalevi Korpela, Professor
Tampere University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2021
First Posted
May 21, 2021
Study Start
January 1, 2019
Primary Completion
March 31, 2021
Study Completion
March 31, 2021
Last Updated
July 1, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share